Carson Wealth (CWM LLC)’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$27.5K Sell
1,999
-450
-18% -$6.78K ﹤0.01% 4226
2025
Q4
$44K Buy
2,449
+889
+57% +$16K ﹤0.01% 3688
2025
Q3
$29K Buy
1,560
+720
+86% +$11.3K ﹤0.01% 3900
2025
Q2
$13K Hold
840
﹤0.01% 4147
2025
Q1
$16K Buy
+840
New +$17.7K ﹤0.01% 3822

Other funds holding CLBT

Carson Wealth (CWM LLC)'s CLBT Position: Q1 2026 in Review

Carson Wealth (CWM LLC) reduced its Cellebrite (CLBT) stake by 18% in Q1 2026, selling an estimated $6.78K and leaving 1,999 shares worth $27.5K. The position accounts for ﹤0.01% of the portfolio, ranked #4226.

Carson Wealth (CWM LLC) first reported a position in CLBT in Q1 2025 and has held it in 5 quarters since. The position peaked at $44K in Q4 2025. 221 funds tracked by Wall St. Rank hold CLBT as of Q1 2026.

  • Carson Wealth (CWM LLC) held 1,999 shares of Cellebrite worth $27.5K as of Q1 2026.
  • Carson Wealth (CWM LLC) sold 450 Cellebrite shares in Q1 2026, an estimated $6.78K.
  • Cellebrite made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #4226 holding.
  • Carson Wealth (CWM LLC) first reported a position in Cellebrite in Q1 2025 and has held it in 5 quarters since.
  • Carson Wealth (CWM LLC)'s Cellebrite position peaked at $44K in Q4 2025.
  • 221 funds tracked by Wall St. Rank held Cellebrite as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.